SCHEMBL23824232

SCHEMBL23824232

CC(C)(C)N(C(CN)N(C(C)(C)C)C(C)(C)C)C(C)(C)C

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.30
CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15329483 0.73 ALDH1A1 (0.35) ALDH1A1
SCHEMBL4259530 0.69
SCHEMBL9468813 0.62
SCHEMBL18354296 0.59 ALDH1A1 (0.33) ALDH1A1
SCHEMBL2925687 0.58 FDPS (0.32) ALDH1A1
SCHEMBL18418441 0.58
SCHEMBL1003622 0.56 ALDH1A1 (0.35) ALDH1A1CYP2D6
Tert-Butylamine SCHEMBL3022813 0.56 ALDH1A1 (0.44) ALDH1A1CYP2D6
SCHEMBL6736147 0.56
Ethylamine SCHEMBL13835333 0.56 CYP2D6 (0.35) CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11124693-B2 Hydroxyalkylurethane kinetic hydrate inhibitors INDORAMA VENTURES OXIDES LLC (US) 2021-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11124693-B2 Hydroxyalkylurethane kinetic hydrate inhibitors HDHD5, UNG, OGG1 ALDH1A1 462/4885CYP2D6 736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.